CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, NSC-79037) in the treatment of cancer. Phase II study.

Cancer ·Vol. 32 ·No. 1 ·1973-07-00 ·Pages 38-43

Hoogstraten B, Gottlieb JA, Caoili E, Tucker WG, Talley RW, Haut A

Abstract

暂无摘要

MeSH Terms

Adenocarcinoma/drug therapy Antiemetics/therapeutic use Bone Marrow/drug effects Capsules Carcinoma, Squamous Cell/drug therapy Chemical and Drug Induced Liver Injury Cyclohexanes Evaluation Studies as Topic Humans Nausea/chemically induced Neoplasms/drug therapy Nitrosourea Compounds/administration & dosage,adverse effects,therapeutic use Vomiting/chemically induced

Chemicals

Antiemetics Capsules Cyclohexanes Nitrosourea Compounds

Authors & Affiliations

6 authors, click to expand affiliations / ORCID

Hoogstraten B

Gottlieb J A

Caoili E

Tucker W G

Talley R W

Haut A

Article Info

Journal

Cancer

Abbr.

Cancer

ISSN

0008-543X

DOI

10.1002/1097-0142(197307)32:1<38::aid-cncr2820320105>3.0.co;2-i

Published

1973-07-00

Pages

38-43

Language

English

Region

United States

NLM ID

0374236

Subset

External Links

PubMed source DOI: 10.1002/1097-0142(197307)32:1<38::aid-cncr2820320105>3.0.co;2-i View journal details

Analysis Services

CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, NSC-79037) in the treatment of cancer. Phase II study.

Contact

WeChat Official Account